Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764190013 | Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3764191012 | Triptorelin (as triptorelin pamoate) 22.5 mg lyophilized powder for suspension for injection vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3786509018 | Triptorelin (as triptorelin pamoate) 22.5 mg lyophilised powder for suspension for injection vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Is a | Product containing triptorelin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has active ingredient | Triptorelin pamoate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has manufactured dose form | Lyophilized powder for conventional release suspension for injection | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has presentation strength numerator value | 22.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has unit of presentation | Vial | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Is a | Product containing only triptorelin in parenteral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has basis of strength substance | Triptorelin | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has presentation strength denominator unit | Vial | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has precise active ingredient | Triptorelin pamoate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR